搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Haemophilus somnus 50S ribosomal protein L17 (rplQ) CSB-YP606495HAAD
CSB-EP606495HAAD
CSB-BP606495HAAD
CSB-MP606495HAAD
CSB-EP606495HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus 50S ribosomal protein L6 (rplF) CSB-YP606496HAAD
CSB-EP606496HAAD
CSB-BP606496HAAD
CSB-MP606496HAAD
CSB-EP606496HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus 30S ribosomal protein S17 (rpsQ) CSB-YP606497HAAD
CSB-EP606497HAAD
CSB-BP606497HAAD
CSB-MP606497HAAD
CSB-EP606497HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus 50S ribosomal protein L22 (rplV) CSB-YP606498HAAD
CSB-EP606498HAAD
CSB-BP606498HAAD
CSB-MP606498HAAD
CSB-EP606498HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Putative Holliday junction resolvase (HS_0010) CSB-YP606499HAAD
CSB-EP606499HAAD
CSB-BP606499HAAD
CSB-MP606499HAAD
CSB-EP606499HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Shikimate dehydrogenase (aroE) CSB-YP606500HAAD
CSB-EP606500HAAD
CSB-BP606500HAAD
CSB-MP606500HAAD
CSB-EP606500HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase (murE) CSB-YP606501HAAD
CSB-EP606501HAAD
CSB-BP606501HAAD
CSB-MP606501HAAD
CSB-EP606501HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP606502HAAD
CSB-EP606502HAAD
CSB-BP606502HAAD
CSB-MP606502HAAD
CSB-EP606502HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Ribosome maturation factor RimM (rimM) CSB-YP606503HAAD
CSB-EP606503HAAD
CSB-BP606503HAAD
CSB-MP606503HAAD
CSB-EP606503HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus UPF0352 protein HS_0229 (HS_0229) CSB-YP606504HAAD
CSB-EP606504HAAD
CSB-BP606504HAAD
CSB-MP606504HAAD
CSB-EP606504HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Isoleucine--tRNA ligase (ileS), partial CSB-YP606505HAAD
CSB-EP606505HAAD
CSB-BP606505HAAD
CSB-MP606505HAAD
CSB-EP606505HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus DNA-binding protein fis (fis) CSB-YP606506HAAD
CSB-EP606506HAAD
CSB-BP606506HAAD
CSB-MP606506HAAD
CSB-EP606506HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Probable ubiquinone biosynthesis protein UbiB (ubiB), partial CSB-YP606507HAAD1
CSB-EP606507HAAD1
CSB-BP606507HAAD1
CSB-MP606507HAAD1
CSB-EP606507HAAD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Dihydrodipicolinate synthase (dapA) CSB-YP606508HAAD
CSB-EP606508HAAD
CSB-BP606508HAAD
CSB-MP606508HAAD
CSB-EP606508HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Glycine--tRNA ligase beta subunit (glyS), partial CSB-YP606509HAAD
CSB-EP606509HAAD
CSB-BP606509HAAD
CSB-MP606509HAAD
CSB-EP606509HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus 60 kDa chaperonin (groL), partial CSB-YP606510HAAD
CSB-EP606510HAAD
CSB-BP606510HAAD
CSB-MP606510HAAD
CSB-EP606510HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Histidine--tRNA ligase (hisS) CSB-YP606511HAAD
CSB-EP606511HAAD
CSB-BP606511HAAD
CSB-MP606511HAAD
CSB-EP606511HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Protein CrcB homolog (crcB), partial CSB-YP606512HAAD1
CSB-EP606512HAAD1
CSB-BP606512HAAD1
CSB-MP606512HAAD1
CSB-EP606512HAAD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Deoxyribose-phosphate aldolase (deoC) CSB-YP606513HAAD
CSB-EP606513HAAD
CSB-BP606513HAAD
CSB-MP606513HAAD
CSB-EP606513HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus D-tyrosyl-tRNA (Tyr) deacylase (dtd) CSB-YP606514HAAD
CSB-EP606514HAAD
CSB-BP606514HAAD
CSB-MP606514HAAD
CSB-EP606514HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>